Monlan, Vanjelyn B.

HRN: 22-45-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/17/2023
01/23/2023
IV
750 Mg
Q8H
TB Meningitis
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes